Review of Different Vaccines and Vaccination Campaings against Covid around the Globe and India
Jahanvi Goyal, Swaroopa Chakole
Journal of Pharmaceutical Research International · pp. 2237–2243 · Published 25 Dec 2021
10.9734/jpri/2021/v33i60B34869Abstract
Background: Coronavirus is caused by beta variant of coronavirus, occurred as an unexpected breakout from the city of Wuhan in China, spreading across borders in no time. A large number of measures like imposing strict curfews, lockdowns, avoidance of public gatherings, home isolation, quarantine etc. have been imposed in the nation to curb the disease transmission, but none of the measures were enough to stop the viral transmission. The only efficient measure to stop the transmission of virus is developing herd immunity by the use of vaccines. As known from the past experiences vaccines take a long time to get approval, but many COVID vaccines have received emergency approval for public use. Vaccines, by creating herd immunity in the population, are the most efficient strategy of limiting the epidemic. Vaccines are the most cost-effective method of preventing infection transmission. Vaccine development typically takes several years, however due to significant mortality; numerous vaccines against COVID-19 have obtained emergency approval. Most of the vaccines developed today or in trial aim at targeting the S protein or the RBD region. There has been remarkable success in development of COVID-19 vaccine since the registration of first case on January 10-2020.Mortality and morbidity associated with the disease are increasing day by day and hence temporary measures like lockdown and stay-at-home strategy would not suffice for long. A large number of vaccination campaigns have been launched around the globe. They aim at reducing the incidence of the disease and henceforth the associated mortality.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Using Ultraviolet A to Check Inanimate Objects for Thorough Cleanliness during COVID-19 Pandemic — shares topic coverage
- The Evaluation of Biochemical Parameters in Positive COVID-19 RealTime PCR Patients: A Retrospective Study — shares topic coverage
- Characteristics of the New Coronavirus Named SARS-CoV-2 Responsible for an Infection Called Coronavirus Disease 2019 (COVID-19) — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.